Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells.

Rushing, Blake R; Molina, Sabrina; Sumner, Susan

Rushing, Blake R; Molina, Sabrina; Sumner, Susan.

Afiliação

Rushing BR; Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Molina S; Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC 28081, USA.
Sumner S; Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC 28081, USA.

Metabolites ; 13(7)2023 Jul 20.

Article em En | MEDLINE | ID: mdl-37512572

Palavras-chave

chemotherapy; doxorubicin; drug resistance; metabolomics; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Metabolites Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google